Plus500 revenue rises 12% as US futures and prediction markets expand

Plus500 reported results for the six months ended 30 June 2026: revenue rose 12% year on year to $462.9 million, Customer Income rose 24% to $460.8 million, and EBITDA increased 1% to $187.5 million. It also announced $182.5 million of shareholder returns, comprising $100 million of buybacks and $82.5 million of dividends.

Event and institutions

Plus500 is a multi-asset fintech group spanning OTC products, share dealing, and US futures and options. The disclosure is a set of corporate interim results, not a regulatory finding and not a promise of investment returns to customers.

The company said it launched a US retail prediction-markets offering in February 2026 and later added sports event contracts regulated by the US Commodity Futures Trading Commission. It also launched a localised Canadian platform and additional stock- and ETF-related products in its OTC business. Full-year revenue and EBITDA guidance remained in line with current market expectations.

Key facts

Revenue grew much faster than EBITDA. Plus500 attributed the gap to higher customer-acquisition spending, revenue-linked costs as its US business scaled, and a short-term foreign-exchange headwind from a stronger Israeli shekel. Revenue expansion and margin performance therefore need to be assessed separately.

The business mix is also shifting. OTC and CFD activity remains central, while US futures clearing and B2B and B2C prediction markets are becoming additional growth channels. These products sit under different entities and regulatory frameworks; group-level figures do not establish the protections available to every customer.

Impact on traders and brokers

Traders should identify the Plus500 legal entity they contract with, the product they use and the applicable regulator. CFDs, exchange-traded futures, options and event contracts differ materially in margin, clearing, client-money protection and dispute procedures. Strong corporate revenue does not determine an individual client’s outcome.

For brokers, the results show how multi-asset platforms can reduce reliance on a single OTC line through local licences, infrastructure and new products. Expansion also raises cross-border compliance, suitability, surveillance and cost-control demands.

TraderVote view

The key signal is the combination of 12% revenue growth and only 1% EBITDA growth. Future disclosures should show whether US initiatives build durable revenue, whether investment converts into lasting customer value, and whether regulatory boundaries remain clear across segments.

TraderVote will continue to verify Plus500 services at the legal-entity and licence level rather than treating group financial performance as a proxy for platform safety or returns.

Sources

Plus500 Investor Relations, H1 2026 Interim Results, 10 August 2026, accessed 19 August 2026:

https://cdn-investors.plus500.com/Reports

RNS announcement mirrored by Investegate, 10 August 2026, accessed 19 August 2026:

https://www.investegate.co.uk/announcement/rns/plus500-ltd-di---plus/plus500-h1-2026-interim-results/9711890

Written by Hengyuan from public disclosures. This article is not investment advice. Verify the contracting entity, product documents and applicable regulatory records.